Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japan’s Ministry Considers Measures To Continue Encephalitis Vaccination

This article was originally published in PharmAsia News

Executive Summary

Facing an effective hiatus on vaccinations for Japanese encephalitis, Japan's Ministry of Health, Labor and Welfare reviewed the issue July 25th and determined that a continuous vaccination is necessary to prevent the disease. Due to a concern of adverse effects, the vaccine's production had been halted, and a new vaccine is still under development. The stockpile of the current vaccine is estimated to run out as early as next April. The ministry is considering prioritizing and limiting the vaccinations to children in the Western area of Japan, which has a higher ratio of virus affected pigs. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069163

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel